Daniel A. Pollyea

University of Colorado Anschutz Medical Campus

Also affiliated with University of Colorado Denver

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 15 papers. Top paper: “Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells”.

Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells

Nature Cancer(2020)10.1038/s43018-020-00126-z

N/A

7.2DataRank · unranked

315 citations

Courtney L. Jones, Daniel A. Pollyea, Rachel Culp‐Hill, Angelo D’Alessandro, Amanda Winters +11 more

Nicotinamide Metabolism Mediates Resistance to Venetoclax in Relapsed Acute Myeloid Leukemia Stem Cells

Cell stem cell(2020)10.1016/j.stem.2020.07.021

N/A

6.2DataRank · unranked

232 citations

Brett M. Stevens, Daniel A. Pollyea, Rachel Culp‐Hill, Julie A. Reisz, Travis Nemkov +17 more

The Hepatic Microenvironment Uniquely Protects Leukemia Cells through Induction of Growth and Survival Pathways Mediated by LIPG

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0318

N/A

0.991DataRank · unranked

32 citations

Mohammad Minhajuddin, Anna Krug, Shanshan Pei, Chih-Hsing Chou, Rachel Culp‐Hill +12 more

A phase 1 study of IO-202, an anti-LILRB4 antibody, in chronic myelomonocytic leukemia and acute myeloid leukemia

Blood Neoplasia(2025)10.1016/j.bneo.2025.100126

N/A

0.330DataRank · unranked

8 citations

Gabriel N. Mannis, Yazan F. Madanat, Brian A. Jonas, Neil Dunavin, Gail J. Roboz +15 more

Plasma lipid levels predict chemotherapy response and survival in acute myeloid leukemia

Blood(2025)10.1182/blood.2025029132

N/A

0.278DataRank · unranked

5 citations

Nirvana Nursimulu, Anit Tyagi, Rachel Culp‐Hill, Andrea Arruda, Tracy Murphy +10 more

The Nicotinamide Salvage Pathway is a Metabolic Vulnerability of High-Risk MDS Stem Cells

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.64898/2025.12.19.695528

N/A

0.104DataRank · unranked

1 citations

Daniel Moskop, Steven Moriera, Stephanie Gipson, Colin C Anderson, Alexendra Crook +24 more

Myelodysplastic neoplasm-associated U2AF1 mutations induce host defense defects by compromising neutrophil chemotaxis

Leukemia(2023)10.1038/s41375-023-02007-7

N/A

0DataRank · unranked

6 citations

Kenneth C. Malcolm, Chelsea Harris, Jennifer R. Knapp, Brian P. O’Connor, Jazalle McClendon +10 more

Targeting Acute Myeloid Leukemia Stem Cells through Perturbation of Mitochondrial Calcium

Cancer Discovery(2024)10.1158/2159-8290.cd-23-1145

N/A

0DataRank · unranked

33 citations

Mark J. Althoff, Hunter Tolison, Krysta L. Engel, Maria L. Amaya, Anna E. Krug +19 more

Lysosomal acid lipase A modulates leukemia stem cell response to venetoclax/tyrosine kinase inhibitor combination therapy in blast phase chronic myeloid leukemia

Haematologica(2024)10.3324/haematol.2023.284716

N/A

0DataRank · unranked

5 citations

Amanda Winters, Haobin Ye, Shanshan Pei, Brett Stevens, Austin E. Gillen +18 more

A Novel Type of Monocytic Leukemia Stem Cell Revealed by the Clinical Use of Venetoclax-Based Therapy

Cancer Discovery(2023)10.1158/2159-8290.cd-22-1297

N/A

0DataRank · unranked

100 citations

Ian T. Shelton, Austin E. Gillen, Brett M. Stevens, Maura Gasparetto, Yanan Wang +20 more

Integrative analysis of drug response and clinical outcome in acute myeloid leukemia

Cancer Cell(2022)10.1016/j.ccell.2022.07.002

N/A

0DataRank · unranked

373 citations

Nicola Long, Anna Reister Schultz, Stephen E. Kurtz, Cristina E. Tognon, Kara Johnson +89 more

Outcomes Are Similar After Allogeneic Hematopoietic Stem Cell Transplant for Newly Diagnosed Acute Myeloid Leukemia Patients who Received Venetoclax + Azacitidine Versus Intensive Chemotherapy

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.07.022

N/A

0DataRank · unranked

45 citations

Grace Bosma, Diana Abbott, Mohd Minhajuddin, Craig T. Jordan, Daniel A. Pollyea +2 more

A novel type of monocytic leukemia stem cell revealed by the clinical use of venetoclax-based therapy

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.12.04.519036

N/A

0DataRank · unranked

12 citations

Austin E. Gillen, Ian T. Shelton, Brett M. Stevens, Maura Gasparetto, Krysta L. Engel +17 more

Monocytic Subclones Confer Resistance to Venetoclax-Based Therapy in Patients with Acute Myeloid Leukemia

Cancer Discovery(2020)10.1158/2159-8290.cd-19-0710

N/A

0DataRank · unranked

555 citations

Daniel A. Pollyea, Annika Gustafson, Brett M. Stevens, Mohammad Minhajuddin, Rui Fu +27 more

Multi-gene measurable residual disease assessed by digital polymerase chain reaction has clinical and biological utility in acute myeloid leukemia patients receiving venetoclax/azacitidine

Haematologica(2023)10.3324/haematol.2023.283790

N/A

0DataRank · unranked

9 citations

Mohd Minhajuddin, Brett M. Stevens, Ajay Major, Grace Bosma, Diana Abbott +9 more